Cargando…
Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines
Autores principales: | Beall, Reed F, Nickerson, Jason W, Attaran, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Medicine Publications, Inc
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242790/ https://www.ncbi.nlm.nih.gov/pubmed/25426181 |
Ejemplares similares
-
Upstream solutions for price-gouging on critical generic medicines
por: Houston, Adam R., et al.
Publicado: (2016) -
In which developing countries are patents on essential medicines being filed?
por: Beall, Reed F, et al.
Publicado: (2017) -
Fostering Canadian drug research and development for neglected tropical diseases
por: Gabriel, Patricia, et al.
Publicado: (2010) -
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
por: Beall, Reed F., et al.
Publicado: (2016) -
Overpriced? Are Hospital Prices Associated with the Quality of Care?
por: Beauvais, Brad, et al.
Publicado: (2020)